
13/07/2022
Resistant bacterial infections cause nearly 5 million deaths every year.
to reduce the use & overuse of antibiotics, which are key drivers of .
(AMR) occurs when:
🔸 bacteria
🔸 viruses
🔸 fungi
🔸 parasites
no longer respond to medicines, ↗️ the risk of disease spread, severe illness & death.
Vaccines are highly effective tools in combating by:
🎯 directly targeting resistant bacteria
🩹 reducing the incidence of both resistant & susceptible infections, thereby ⬇️ consumption, which is a key driver of AMR.
The analysis identifies 61 vaccine candidates in various stages of clinical development, including several vaccine candidates against priority pathogens that are in late stages of development. Most of these vaccines will not be available anytime soon.
The new report stresses that access to these vaccines should be increased globally, especially among populations that need them most in limited resource settings.
🆕 report describes all vaccines currently in development for priority bacterial pathogens ⬇️
https://bit.ly/3uH3Xic